Posted on 2/1/21
Johnson & Johnson Says Its One-Dose Coronavirus Vaccine Was 66% Effective in Clinical Trial
Johnson & Johnson (NYSE:JNJ) released results today from the phase 3 clinical trial of its COVID-19 vaccine candidate, saying that the data showed it was 66% . . .
Posted on 2/1/21
Which Is the Best COVID Vaccine Stock: Pfizer, BioNTech, Moderna, Johnson & Johnson, or Novavax?
Which COVID-19 vaccine is the best? The correct answer is that it depends on which factor is most important to you.Comirnaty (BNT162b2), the vaccine developed by . . .
Posted on 1/30/21
Scopus BioPharma Closes $9M Follow-On Public Offering
Scopus BioPharma Inc. (Nasdaq: SCPS) today announced the closing of a $9 million follow-on public offering. The offering consisted of 1,000,000 shares of common stock at . . .
Posted on 1/30/21
Bioasis Announces $200,000 Non-Brokered Private Placement
GUILFORD, Conn., Jan. 29, 2021 (GLOBE NEWSWIRE) -- BIOASIS TECHNOLOGIES INC. (OTCQB:BIOAF; TSX.V:BTI), a pre-clinical, research-stage biopharmaceutical company developing its proprietary xB3 ™ platform technology for . . .
Posted on 1/29/21
VYNE Therapeutics Closes of $50 Million Registered Direct Offering of Common Stock
BRIDGEWATER, N.J., Jan. 29, 2021 (GLOBE NEWSWIRE) -- VYNE Therapeutics Inc. (Nasdaq: VYNE) today announced that it has closed its previously announced registered direct offering of . . .
Posted on 1/29/21
Better Buy: Pfizer vs. BioNTech
Pfizer (NYSE:PFE) and BioNTech (NASDAQ:BNTX) together pulled off one of the greatest accomplishments in medical history by developing a safe and highly effective COVID-19 vaccine in . . .
Posted on 1/28/21
Seelos Therapeutics Closes of Public Offering of Common Stock
Seelos Therapeutics, Inc. (Nasdaq: SEEL), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system disorders and rare diseases, announced today the . . .
Posted on 1/28/21
Ortho Clinical Diagnostics Prices IPO
Ortho Clinical Diagnostics Holdings plc, the world's largest pure-play in vitro diagnostics company dedicated to improving and saving lives through innovative laboratory testing and blood-typing solutions, . . .
Posted on 1/27/21
Citius Pharmaceuticals Closes of $20.0 Million Private Placement
Citius Pharmaceuticals, Inc. (Nasdaq: CTXR), a specialty pharmaceutical company focused on developing and commercializing critical care drug products, today announced that it has closed on the . . .
Posted on 1/27/21
DarioHealth Acquires Upright Technologies
DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics (DTx) market, announced today the signing of a definitive agreement to acquire digital musculoskeletal (MSK) . . .
Posted on 1/27/21
Cedar Partnership with Yale New Haven Health
Yale New Haven Health (YNHHS), one of the nation's leading Academic Medical Centers, and Cedar, an innovative patient engagement and financial technology platform, announced an Innovation . . .
Posted on 1/27/21
Thermo Fisher Scientific Launches First T-cell Medium Specifically
Novel media supports automated T-cell expansion to deliver scalable, cost-effective cell therapy treatmentsThermo Fisher Scientific has developed a new medium for the development and expansion of . . .
Posted on 1/27/21
Comcast Ties Up With WWE in Peacock Streaming Deal
Comcast (NASDAQ:CMCSA) is pushing its Peacock streaming video service into the wrestling ring. The big broadcaster has signed a multi-year deal with World Wrestling Entertainment (NYSE:WWE) . . .
Posted on 1/27/21
Why Pfizer Will Make More Money Than Originally Expected in 2021
We've all known for quite a while that Pfizer (NYSE:PFE) was likely to make billions of dollars from its COVID-19 vaccine. Granted, the big drugmaker has . . .
Posted on 1/27/21
Should You Buy Johnson & Johnson Stock Before Its Big Coronavirus Vaccine News?
The biggest healthcare company in the world has some really big news on the way. Johnson & Johnson (NYSE:JNJ) should announce results from a late-stage study . . .
Posted on 1/27/21
Is Pfizer A Great Dividend Stock?
Companies have a limited number of choices when deciding what to do with the money they earn. For mature businesses with relatively predictable earnings, a portion . . .
Posted on 1/27/21
Here's Why Investors Cheered Johnson & Johnson's Q4 Results
Johnson & Johnson (NYSE:JNJ) delivered a return of nearly 8% in 2020. Adding in the company's dividend gives a total return of close to 11%. That's . . .
Posted on 1/27/21
Johnson & Johnson Rises on Q4 Beats, Coronavirus Vaccine Hopes
Johnson & Johnson (NYSE:JNJ) delivered an encouraging set of quarterly results on Tuesday, which included a promising -- albeit limited -- update on its coronavirus vaccine . . .
Posted on 1/27/21
Scopus BioPharma Announces Pricing of $9 Million Follow-On Public Offering
Scopus BioPharma Inc. (Nasdaq: "SCPS") today announced the pricing of a $9 million follow-on public offering. The offering consists of 1,000,000 shares of common stock at . . .
Posted on 1/26/21
Johnson & Johnson Reports 2020 Fourth-Quarter And Full Year Results
Johnson & Johnson (NYSE: JNJ) today announced results for fourth-quarter and full year 2020. "Our notable full year performance reflects the continued confidence from patients, physicians, . . .
Posted on 1/26/21
Seelos Therapeutics Prices of $31.25 Million Public Offering of Common Stock
Seelos Therapeutics, Inc. (Nasdaq: SEEL), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system disorders and rare diseases, announced today the . . .
Posted on 1/26/21
VYNE Therapeutics Sale of $50 Million Registered Direct Offering of Common Stock
BRIDGEWATER, N.J., Jan. 26, 2021 (GLOBE NEWSWIRE) -- VYNE Therapeutics Inc. (Nasdaq: VYNE) today announced that it has entered into definitive agreements with institutional and accredited . . .
Posted on 1/26/21
Pacira BioSciences Equity Invest in GeneQuine Biotherapeutics
PARSIPPANY, N.J., Jan. 26, 2021 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the leading provider of innovative non-opioid pain management options, today announced that the . . .
Posted on 1/26/21
Grant Avenue Capital Acquires Valeo Home Health and Hospice
Grant Avenue Capital, LLC, a healthcare-focused private equity firm, announced today that it acquired a majority interest in Valeo Home Health and Hospice, based in Salt . . .
Posted on 1/26/21
States that Have the Fewest COVID-19 Restrictions – Updated WalletHub Study
With the U.S. starting to open up more but a full reopening only possible once we achieve widespread vaccination, the personal-finance website WalletHub today released updated . . .
New York
